As of 2025-07-05, the Relative Valuation of ANI Pharmaceuticals Inc (ANIP) is (1.63) USD. This relative valuation is based on P/E multiples. With the latest stock price at 65.28 USD, the upside of ANI Pharmaceuticals Inc based on Relative Valuation is -102.5%.
The range of the Relative Valuation is (1.67) - (1.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 11.9x | 9.8x |
| Forward P/E multiples | 12.7x - 17.0x | 15.1x |
| Fair Price | (1.67) - (1.56) | (1.63) |
| Upside | -102.6% - -102.4% | -102.5% |
| Date | P/E |
| 2025-07-03 | -497.47 |
| 2025-07-02 | -497.01 |
| 2025-07-01 | -484.36 |
| 2025-06-30 | -497.24 |
| 2025-06-27 | -499.15 |
| 2025-06-26 | -501.51 |
| 2025-06-25 | -502.27 |
| 2025-06-24 | -510.42 |
| 2025-06-23 | -503.19 |
| 2025-06-20 | -499.60 |
| 2025-06-18 | -492.75 |
| 2025-06-17 | -482.76 |
| 2025-06-16 | -489.93 |
| 2025-06-13 | -476.74 |
| 2025-06-12 | -473.39 |
| 2025-06-11 | -478.42 |
| 2025-06-10 | -479.10 |
| 2025-06-09 | -481.47 |
| 2025-06-06 | -472.17 |
| 2025-06-05 | -456.32 |
| 2025-06-04 | -463.86 |
| 2025-06-03 | -469.88 |
| 2025-06-02 | -471.79 |
| 2025-05-30 | -447.48 |
| 2025-05-29 | -443.97 |
| 2025-05-28 | -440.54 |
| 2025-05-27 | -444.43 |
| 2025-05-23 | -440.39 |
| 2025-05-22 | -436.43 |
| 2025-05-21 | -450.22 |
| 2025-05-20 | -462.11 |
| 2025-05-19 | -458.45 |
| 2025-05-16 | -457.16 |
| 2025-05-15 | -453.65 |
| 2025-05-14 | -460.05 |
| 2025-05-13 | -472.47 |
| 2025-05-12 | -474.76 |
| 2025-05-09 | -505.24 |
| 2025-05-08 | -545.10 |
| 2025-05-07 | -539.69 |
| 2025-05-06 | -535.50 |
| 2025-05-05 | -552.95 |
| 2025-05-02 | -555.92 |
| 2025-05-01 | -538.70 |
| 2025-04-30 | -539.69 |
| 2025-04-29 | -539.23 |
| 2025-04-28 | -539.15 |
| 2025-04-25 | -532.07 |
| 2025-04-24 | -530.70 |
| 2025-04-23 | -521.02 |